Clinical Trials Update: May 15, 2007
COPD (Chronic Obstructive Pulmonary Disease) Gout (Hyperuricemia) Bladder Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
COPD (Chronic Obstructive Pulmonary Disease)
If you have been diagnosed with chronic obstructive pulmonary disease (COPD), you may qualify for this clinical study of an investigational medication. Symptoms of COPD include frequent cough, shortness of breath, wheezing, and excess mucus or phlegm.
The research site is in Houston, Texas .
You may be eligible for this study if you have symptoms of gout, including pain, swelling, and tenderness in the joints. The study will evaluate an investigational drug to see if it lowers levels of uric acid. Volunteers 18-85 who are not breast feeding or pregnant and have no history of xanthinuria or cancer may be eligible.
The research site is in Nashville, Tenn.
This study will compare regimens of vinflunine/gemcitabine, versus a placebo/gemcitabine. Candidates with a diagnosis of primarily TCC cancer of the bladder, kidney, renal pelvis, or ureter may be included.
The research site is in Morgantown, WV.
Copyright 2007 Thomson CenterWatch. All rights reserved.